IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.02M | -140.06M | -113.70M | -160.74M | -331.80M |
| Total Depreciation and Amortization | 4.49M | 4.60M | 4.59M | 4.04M | 4.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.47M | 43.01M | 36.14M | 30.44M | 24.06M |
| Change in Net Operating Assets | 9.40M | 6.53M | 1.87M | 24.00M | 10.02M |
| Cash from Operations | -111.66M | -85.93M | -71.10M | -102.26M | -293.71M |
| Capital Expenditure | -2.21M | -2.01M | -2.37M | -3.14M | -3.55M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.53M | 111.12M | 72.34M | -26.47M | -87.86M |
| Cash from Investing | -92.74M | 109.11M | 69.98M | -29.61M | -91.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 221.82M | 4.83M | 29.78M | 30.40M | 307.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 141.00M | -9.00K | -- | 0.00 | 9.40M |
| Cash from Financing | 362.82M | 4.82M | 29.78M | 30.40M | 316.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.42M | 28.00M | 28.66M | -101.46M | -68.51M |